Administration of axitinib

2 trials

Sponsors

Kyorin University, School of Medicine

Conditions

Unresectable or recurrent bilary tract cancerUnresectable or recurrent biliary tract cancer

Phase 2

A phase II study of axitinib for biliary tract cancer refractory to gemcitabine-based chemotherapy

RecruitingJPRN-UMIN000010520

Kyorin University, School of MedicineUnresectable or recurrent bilary tract cancer

Start: 2013-04-18Target: 32Updated: 2026-06-29

A study of axitinib for biliary tract cancer refractory to gemcitabine-based chemotherapy

Active, not recruitingJPRN-UMIN000023014

Kyorin University, School of MedicineUnresectable or recurrent biliary tract cancer

Start: 2016-07-06Target: 32Updated: 2026-06-29